LIA
PRAH

LS Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

LS Investment Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,524
Closed -$540K – 797
2021
Q1 		$540K Sell
3,524
-705
-17% -$95.7K 0.03% 362
2020
Q4 		$530K Hold
4,229
– – 0.03% 410
2020
Q3 		$429K Sell
4,229
-69
-2% -$7.04K 0.02% 438
2020
Q2 		$418K Buy
4,298
+156
+4% +$14.5K 0.03% 434
2020
Q1 		$344K Hold
4,142
– – 0.02% 430
2019
Q4 		$460K Sell
4,142
-555
-12% -$57.1K 0.02% 511
2019
Q3 		$466K Buy
4,697
+133
+3% +$13.2K 0.03% 478
2019
Q2 		$453K Sell
4,564
-223
-5% -$21.3K 0.03% 486
2019
Q1 		$528K Buy
4,787
+22
+0.5% +$2.3K 0.03% 439
2018
Q4 		$438K Buy
4,765
+716
+18% +$72.4K 0.03% 456
2018
Q3 		$446K Buy
4,049
+784
+24% +$81.6K 0.03% 546
2018
Q2 		$305K Buy
+3,265
New +$281K 0.02% 688

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

LS Investment Advisors's PRAH Position: Q2 2021 in Review

LS Investment Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 3,524 shares — an estimated $540K sold.

LS Investment Advisors first reported a position in PRAH in Q2 2018 and held it in 12 quarters. The position peaked at $540K in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • LS Investment Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 3,524 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $540K.
  • LS Investment Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 12 quarters.
  • LS Investment Advisors's PRA Health Sciences, Inc. position peaked at $540K in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.